AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Ways To Escape Financial Traps In Budgeting emphasize redefining goals, trimming excess spending, and maintaining budgeting discipline.
17,893 articlesAbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Insider moves can signal a lot about a company’s near-term plans and risk. This deep dive looks at Adaptive Biotechno...
Suncor Energy has climbed sharply this year, but is the rally justified for new buyers? This guide breaks down the dr...
When a top executive sells a large block of stock, investors want to know whether it signals trouble or simply person...
Bitcoin and Ethereum jumped after cooler-than-expected U.S. inflation data, while Japan’s Upper House committee advan...
Got $1,000 to invest? This article outlines a real-world plan, explains why Nvidia makes sense before Micron, and giv...
Energy markets pivot as renewables rise and fossil fuels adapt; several penny stocks are drawing attention for their ...
Greystone Real Estate Capital closes its second LIHTC-focused fund at 137 million, expanding its LIHTC equity to over...
WD-40 has evolved from a single iconic spray into a disciplined maintenance-products company. This deep dive explains...
A viral comparison claims pokémon cards beat 2.5x the S&P 500 over two decades, but analysts warn that rising fees, i...
As Anthropic eyes an IPO, a potential $1.2 trillion valuation could ripple through AI stocks. This piece breaks down ...
Moldova’s parliament elects 44-year-old businessman Vasile Tofan as prime minister after a 53-21 vote. Investors and ...